Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahir Garabatos

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|May 16, 2022
Gut Microbial Antigenic Mimicry in AutoimmunityNahir Garabatos, Pere Santamaria
The Journal of Allergy and Clinical Immunology|August 9, 2025
Mechanistic and therapeutic advances in immune-mediated gastrointestinal disordersNahir Garabatos, Edgar Angelats, Pere Santamaria
The Journal of Allergy and Clinical Immunology|March 4, 2021
Optimal human pathogenic T<sub>H</sub>2 cell effector function requires local epithelial cytokine signalingJustine Calise, Nahir Garabatos, Veronique Bajzik, et al.
Scientific Reports|May 27, 2018
Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramersCristina Izquierdo, Angela Zarama Ortiz, Maximiliano Presa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouseElisa I Rivas, John P Driver, Nahir Garabatos, et al.
European Journal of Immunology|August 9, 2013
Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant miceMaximiliano Presa, Angela Zarama Ortiz, Nahir Garabatos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2021
Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicinesYang Yang, Kristofor K Ellestad, Santiswarup Singha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2014
In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesisNahir Garabatos, Raimon Alvarez, Jorge Carrillo, et al.
Frontiers in Immunology|May 8, 2023
Transcriptional re-programming of insulin B-chain epitope-specific T-follicular helper cells into anti-diabetogenic T-regulatory type-1 cellsPatricia Solé, Daniel Parras, Jun Yamanouchi, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|October 31, 2014
A monoclonal antibody against the extracellular domain of mouse and human epithelial V-like antigen 1 reveals a restricted expression pattern among CD4- CD8- thymocytesNahir Garabatos, Jesus Blanco, Cesar Fandos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 16, 2022
Gut Microbial Antigenic Mimicry in AutoimmunityNahir Garabatos, Pere Santamaria
The Journal of Allergy and Clinical Immunology|August 9, 2025
Mechanistic and therapeutic advances in immune-mediated gastrointestinal disordersNahir Garabatos, Edgar Angelats, Pere Santamaria
The Journal of Allergy and Clinical Immunology|March 4, 2021
Optimal human pathogenic T<sub>H</sub>2 cell effector function requires local epithelial cytokine signalingJustine Calise, Nahir Garabatos, Veronique Bajzik, et al.
Scientific Reports|May 27, 2018
Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramersCristina Izquierdo, Angela Zarama Ortiz, Maximiliano Presa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouseElisa I Rivas, John P Driver, Nahir Garabatos, et al.
European Journal of Immunology|August 9, 2013
Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant miceMaximiliano Presa, Angela Zarama Ortiz, Nahir Garabatos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2021
Extremely short bioavailability and fast pharmacodynamic effects of pMHC-based nanomedicinesYang Yang, Kristofor K Ellestad, Santiswarup Singha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2014
In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesisNahir Garabatos, Raimon Alvarez, Jorge Carrillo, et al.
Frontiers in Immunology|May 8, 2023
Transcriptional re-programming of insulin B-chain epitope-specific T-follicular helper cells into anti-diabetogenic T-regulatory type-1 cellsPatricia Solé, Daniel Parras, Jun Yamanouchi, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|October 31, 2014
A monoclonal antibody against the extracellular domain of mouse and human epithelial V-like antigen 1 reveals a restricted expression pattern among CD4- CD8- thymocytesNahir Garabatos, Jesus Blanco, Cesar Fandos, et al.
Pageof 2